Open Access Paper
23 February 2013 Nanoelectroablation for human carcinoma therapy
Richard Nuccitelli, Mark Kreis, Brian Athos, Ryan Wood, Joanne Huynh, Kaying Lui, Pamela Nuccitelli, Ervin Epstein
Author Affiliations +
Abstract
The use of nanosecond pulsed electric fields to ablate tumors (nanoelectroablation) is now well established in the murine xenograft model system. In order bring this therapy into the clinic for the treatment of human tumors we are developing both a pulse generator as well as delivery electrodes to target the tumors to be treated. We will describe the PulseCure® Model MBR-1 100 ns pulse generator and the first human clinical trial data using nanoelectroablation to scarlessly ablate basal cell carcinomas.
© (2013) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Richard Nuccitelli, Mark Kreis, Brian Athos, Ryan Wood, Joanne Huynh, Kaying Lui, Pamela Nuccitelli, and Ervin Epstein "Nanoelectroablation for human carcinoma therapy", Proc. SPIE 8585, Terahertz and Ultrashort Electromagnetic Pulses for Biomedical Applications, 85850G (23 February 2013); https://doi.org/10.1117/12.2002538
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Plasma

Tissues

Electrodes

Melanoma

Skin

Tumor growth modeling

Back to Top